Publications by Chloe Beate Steen

21 publications found

Publications 2024

  1. Bai B, Wise JF, Vodák D, Nakken S, Sharma A, Blaker YN, Brodtkorb M, Hilden V, Trøen G, Ren W, Lorenz S, Lawrence MS, Myklebost O, Kimby E, Pan-Hammarström Q, Steen CB, Meza-Zepeda LA, Beiske K, Smeland EB, Hovig E, Lingjærde OC, Holte H, Myklebust JH (2024)
    Multi-omics profiling of longitudinal samples reveals early genomic changes in follicular lymphoma
    Blood Cancer J, 14 (1), 147
    DOI 10.1038/s41408-024-01124-5, PubMed 39191762

Publications 2023

  1. Spasevska I, Sharma A, Steen CB, Josefsson SE, Blaker YN, Kolstad A, Rustad EH, Meyer S, Isaksen K, Chellappa S, Kushekhar K, Beiske K, Førsund MS, Spetalen S, Holte H, Østenstad B, Brodtkorb M, Kimby E, Olweus J, Taskén K, Newman AM, Lorenz S, Smeland EB, Alizadeh AA, Huse K et al. (2023)
    Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma
    Blood Adv, 7 (23), 7216-7230
    DOI 10.1182/bloodadvances.2023010158, PubMed 37695745
  2. Steen CB, Luca BA, Alizadeh AA, Gentles AJ, Newman AM (2023)
    Profiling Cellular Ecosystems at Single-Cell Resolution and at Scale with EcoTyper
    Methods Mol Biol, 2629, 43-71
    DOI 10.1007/978-1-0716-2986-4_4, PubMed 36929073
  3. Vahid MR, Brown EL, Steen CB, Zhang W, Jeon HS, Kang M, Gentles AJ, Newman AM (2023)
    High-resolution alignment of single-cell and spatial transcriptomes with CytoSPACE
    Nat Biotechnol, 41 (11), 1543-1548
    DOI 10.1038/s41587-023-01697-9, PubMed 36879008

Publications 2022

  1. Esfahani MS, Hamilton EG, Mehrmohamadi M, Nabet BY, Alig SK, King DA, Steen CB, Macaulay CW, Schultz A, Nesselbush MC, Soo J, Schroers-Martin JG, Chen B, Binkley MS, Stehr H, Chabon JJ, Sworder BJ, Hui AB, Frank MJ, Moding EJ, Liu CL, Newman AM, Isbell JM, Rudin CM, Li BT et al. (2022)
    Inferring gene expression from cell-free DNA fragmentation profiles
    Nat Biotechnol, 40 (4), 585-597
    DOI 10.1038/s41587-022-01222-4, PubMed 35361996
  2. Lozano AX, Chaudhuri AA, Nene A, Bacchiocchi A, Earland N, Vesely MD, Usmani A, Turner BE, Steen CB, Luca BA, Badri T, Gulati GS, Vahid MR, Khameneh F, Harris PK, Chen DY, Dhodapkar K, Sznol M, Halaban R, Newman AM (2022)
    T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma
    Nat Med, 28 (2), 353-362
    DOI 10.1038/s41591-021-01623-z, PubMed 35027754
  3. Sikandar SS, Gulati GS, Antony J, Fetter I, Kuo AH, Ho WHD, Haro-Acosta V, Das S, Steen CB, Pereira TA, Qian D, Beachy PA, Dirbas FM, Red-Horse K, Rabbitts TH, Thiery JP, Newman AM, Clarke MF (2022)
    Identification of a minority population of LMO2+ breast cancer cells that integrate into the vasculature and initiate metastasis
    Sci Adv, 8 (45), eabm3548
    DOI 10.1126/sciadv.abm3548, PubMed 36351009

Publications 2021

  1. Luca BA, Steen CB, Matusiak M, Azizi A, Varma S, Zhu C, Przybyl J, Espín-Pérez A, Diehn M, Alizadeh AA, van de Rijn M, Gentles AJ, Newman AM (2021)
    Atlas of clinically distinct cell states and ecosystems across human solid tumors
    Cell, 184 (21), 5482-5496.e28
    DOI 10.1016/j.cell.2021.09.014, PubMed 34597583
  2. Steen CB, Luca BA, Esfahani MS, Azizi A, Sworder BJ, Nabet BY, Kurtz DM, Liu CL, Khameneh F, Advani RH, Natkunam Y, Myklebust JH, Diehn M, Gentles AJ, Newman AM, Alizadeh AA (2021)
    The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma
    Cancer Cell, 39 (10), 1422-1437.e10
    DOI 10.1016/j.ccell.2021.08.011, PubMed 34597589

Publications 2020

  1. Nabet BY, Esfahani MS, Moding EJ, Hamilton EG, Chabon JJ, Rizvi H, Steen CB, Chaudhuri AA, Liu CL, Hui AB, Almanza D, Stehr H, Gojenola L, Bonilla RF, Jin MC, Jeon YJ, Tseng D, Liu C, Merghoub T, Neal JW, Wakelee HA, Padda SK, Ramchandran KJ, Das M, Plodkowski AJ et al. (2020)
    Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint Inhibition
    Cell, 183 (2), 363-376.e13
    DOI 10.1016/j.cell.2020.09.001, PubMed 33007267
  2. Steen CB, Liu CL, Alizadeh AA, Newman AM (2020)
    Profiling Cell Type Abundance and Expression in Bulk Tissues with CIBERSORTx
    Methods Mol Biol, 2117, 135-157
    DOI 10.1007/978-1-0716-0301-7_7, PubMed 31960376
  3. Wise JF, Nakken S, Steen CB, Vodák D, Trøen G, Johannessen B, Lingjærde OC, Hilden V, Blaker YN, Bai B, Aasheim LB, Pasanen A, Lorenz S, Sveen A, Lothe RA, Myklebost O, Leppä S, Meza-Zepeda LA, Beiske K, Lawrence MS, Hovig E, Myklebust JH, Smeland EB, Holte H (2020)
    Mutational dynamics and immune evasion in diffuse large B-cell lymphoma explored in a relapse-enriched patient series
    Blood Adv, 4 (9), 1859-1866
    DOI 10.1182/bloodadvances.2019001325, PubMed 32374878

Publications 2019

  1. Liu CC, Steen CB, Newman AM (2019)
    Computational approaches for characterizing the tumor immune microenvironment
    Immunology, 158 (2), 70-84
    DOI 10.1111/imm.13101, PubMed 31347163
  2. Newman AM, Steen CB, Liu CL, Gentles AJ, Chaudhuri AA, Scherer F, Khodadoust MS, Esfahani MS, Luca BA, Steiner D, Diehn M, Alizadeh AA (2019)
    Determining cell type abundance and expression from bulk tissues with digital cytometry
    Nat Biotechnol, 37 (7), 773-782
    DOI 10.1038/s41587-019-0114-2, PubMed 31061481
  3. Steen CB, Leich E, Myklebust JH, Lockmer S, Wise JF, Wahlin BE, Østenstad B, Liestøl K, Kimby E, Rosenwald A, Smeland EB, Holte H, Lingjærde OC, Brodtkorb M (2019)
    A clinico-molecular predictor identifies follicular lymphoma patients at risk of early transformation after first-line immunotherapy
    Haematologica, 104 (10), e460-e464
    DOI 10.3324/haematol.2018.209080, PubMed 30846496

Publications 2018

  1. Lockmer S, Østenstad B, Hagberg H, Holte H, Johansson AS, Wahlin BE, Wader KF, Steen CB, Meyer P, Maisenhølder M, Smedby KE, Brown P, Kimby E (2018)
    Chemotherapy-Free Initial Treatment of Advanced Indolent Lymphoma Has Durable Effect With Low Toxicity: Results From Two Nordic Lymphoma Group Trials With More Than 10 Years of Follow-Up
    J Clin Oncol, 36 (33), 3315-+
    DOI 10.1200/JCO.18.00262, PubMed 30285560
  2. Våtsveen TK, Myhre MR, Steen CB, Wälchli S, Lingjærde OC, Bai B, Dillard P, Theodossiou TA, Holien T, Sundan A, Inderberg EM, Smeland EB, Myklebust JH, Oksvold MP (2018)
    Artesunate shows potent anti-tumor activity in B-cell lymphoma
    J Hematol Oncol, 11 (1), 23
    DOI 10.1186/s13045-018-0561-0, PubMed 29458389

Publications 2017

  1. Josefsson SE, Huse K, Kolstad A, Beiske K, Pende D, Steen CB, Inderberg EM, Lingjærde OC, Østenstad B, Smeland EB, Levy R, Irish JM, Myklebust JH (2017)
    T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized by Reversible Suppression of T-cell Receptor Signaling
    Clin Cancer Res, 24 (4), 870-881
    DOI 10.1158/1078-0432.CCR-17-2337, PubMed 29217528

Publications 2016

  1. Knudsen MD, de Lange T, Botteri E, Nguyen DH, Evensen H, Steen CB, Hoff G, Bernklev T, Hjartåker A, Berstad P (2016)
    Favorable lifestyle before diagnosis associated with lower risk of screen-detected advanced colorectal neoplasia
    World J Gastroenterol, 22 (27), 6276-86
    DOI 10.3748/wjg.v22.i27.6276, PubMed 27468217

Publications 2015

  1. Eikenes ÅH, Malerød L, Christensen AL, Steen CB, Mathieu J, Nezis IP, Liestøl K, Huynh JR, Stenmark H, Haglund K (2015)
    ALIX and ESCRT-III coordinately control cytokinetic abscission during germline stem cell division in vivo
    PLoS Genet, 11 (1), e1004904
    DOI 10.1371/journal.pgen.1004904, PubMed 25635693

Publications 2013

  1. Randen U, Trøen G, Tierens A, Steen C, Warsame A, Beiske K, Tjønnfjord GE, Berentsen S, Delabie J (2013)
    Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma
    Haematologica, 99 (3), 497-504
    DOI 10.3324/haematol.2013.091702, PubMed 24143001

 
Scroll to top